ICD-10-CM code · FY2027
C82.04 Follicular lymphoma grade I, lymph nodes of axilla and upper limb
BillableValid for claims as a specific diagnosis code
About C82.04
Ask EvidencePulse about follicular lymphoma
Answers from the published evidence, with every study linked. The question goes into the box; nothing is sent until you press Ask.
Coding notes for C82.04
No notes of its own; the notes below apply from the codes above it.
Also applies, from C82 Follicular lymphoma
Includes Conditions this code covers.
- follicular lymphoma with or without diffuse areas
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Block C81-C96 notes (apply to every code in it)
Chapter 2 notes (apply to every code in it)
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Related codes in C82.0
- C82.00 Follicular lymphoma grade I, unspecified siteBillable
- C82.01 Follicular lymphoma grade I, lymph nodes of head, face, and neckBillable
- C82.02 Follicular lymphoma grade I, intrathoracic lymph nodesBillable
- C82.03 Follicular lymphoma grade I, intra-abdominal lymph nodesBillable
- C82.05 Follicular lymphoma grade I, lymph nodes of inguinal region and lower limbBillable
- C82.06 Follicular lymphoma grade I, intrapelvic lymph nodesBillable
- C82.07 Follicular lymphoma grade I, spleenBillable
- C82.08 Follicular lymphoma grade I, lymph nodes of multiple sitesBillable
- C82.09 Follicular lymphoma grade I, extranodal and solid organ sitesBillable
- C82.0A Follicular lymphoma grade I, in remissionBillable
Latest research on follicular lymphoma
- Incyte: Monjuvi improves survival in patients with relapsed or refractory follicular lymphoma
- Prolonged rituximab maintenance therapy does not provide overall survival benefit in low-burden follicular lymphoma
- #VisualAbstract: Rituximab plus lenalidomide shows comparable survival compared to chemotherapy for CD20⁺ follicular lymphoma
- #VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma
- #VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plans